Avedro, Inc.
IPO News: Filed S-1/A: Avedro Launches 5mm Share IPO with $14-$16 Marketing Range
Avedro, Inc.



Initial Filing Date:  01/18/19

Launch Date:  02/04/19

Price Range:  $14.00 - $16.00

Shares Offered (Pre-Shoe | mm):  5.0

Primary Shares (mm):  5.0

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $75.0

% Secondary:  0.0%

Shares Outstanding (mm):  17.1

Market Value at Midpoint (mm):  $255.9

Offering as % of Market Value:  29.3%

Bookrunners:  Bank of America Merrill Lynch | J.P. Morgan

Co-Managers:  Cowen | Guggenheim | Leerink

Major Holders:  OrbiMed Advisors | InterWest Partners | HealthQuest Partners | LAV | De Novo Ventures

Description:  Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses.

Note:  Emerging Growth Company


Reference Link: Filed S-1/A